{"nct_id":"NCT02688387","title":"A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2016-03-18","start_date_type":"ACTUAL","primary_completion_date":"2017-08-04","primary_completion_date_type":"ACTUAL","completion_date":"2017-08-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}